Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Amarin Corporation plc (ADR) - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
AMRN
Nasdaq
2834
https://amarincorp.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Amarin Corporation plc (ADR)
Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event
- Apr 24th, 2024 6:00 pm
Amarin Announces Results of Annual General Meeting of Shareholders
- Apr 22nd, 2024 12:00 pm
Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024
- Apr 15th, 2024 12:00 pm
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24
- Apr 8th, 2024 12:00 pm
New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
- Apr 8th, 2024 10:30 am
New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
- Apr 6th, 2024 7:30 pm
Amarin (AMRN) Up 7% on Intellectual Property Wins in Europe
- Apr 4th, 2024 5:20 pm
Why Amarin Stock Was Rocketing Higher on Wednesday
- Apr 3rd, 2024 8:13 pm
Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe
- Apr 3rd, 2024 12:00 pm
Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo
- Mar 25th, 2024 12:00 pm
Amarin Full Year 2023 Earnings: Beats Expectations
- Mar 5th, 2024 1:09 pm
Earnings Update: Amarin Corporation plc (NASDAQ:AMRN) Just Reported And Analysts Are Trimming Their Forecasts
- Mar 2nd, 2024 1:00 pm
Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates
- Mar 1st, 2024 2:30 pm
Amarin Corporation plc (NASDAQ:AMRN) Q4 2023 Earnings Call Transcript
- Mar 1st, 2024 1:39 pm
Amarin Plc (AMRN) Q4 2023 Earnings Call Transcript
- Feb 29th, 2024 8:30 pm
Amarin Corp PLC (AMRN) Faces Revenue Decline Amidst Generic Competition
- Feb 29th, 2024 12:34 pm
Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Feb 29th, 2024 12:00 pm
Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024
- Feb 15th, 2024 1:00 pm
5 Biotech Stocks Likely to Outpace Q4 Earnings Estimates
- Feb 15th, 2024 10:45 am
Amarin Chairman & CEO Issue Letter to Shareholders
- Jan 22nd, 2024 12:30 pm
Scroll